Letter to Our Shareholders
WACKER’s performance in 2018 was marked by the strength of our chemical business and by difficult conditions in the solar market. Overall, sales rose by 1 percent to €4.98 billion. EBITDA (earnings before interest, taxes, depreciation and amortization) came in at €930 million, 8 percent lower than the year before.
Biotechnology
Chemistry for Life
Biotechnology Solutions
Our Business at a Glance
How Biotech Enters All Areas of Our Lives
Ten Answers
Beneficial Bacteria
Tomorrow’s Medicines
Microbes as Factories
Cystine by Crowdsourcing
New Ingredients
Sugar Rings for Baking
The Power of Plants
Healthy from Within
Hidden Talents
Self-Healing Car Paint
Innovations
Ideas That Create the Future
WACKER’s Production and Sales Sites and Technical Competence Centers1
Find out moreProduction site
Sales site
Technical competence center
Amount of WACKER-representations and production sites for this area.